Cefs-S 500mg/250mg Injection
Marketer
Shreshtha Formulations
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Cefs-S 500mg/250mg Injection
Cef-S 500mg/250mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and spread. Administration must be overseen by a qualified healthcare provider. Consistent adherence to the prescribed dosage schedule is crucial; prematurely stopping treatment may compromise its effectiveness. Complete the full course, even with symptom improvement. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or worsening side effects necessitate immediate medical attention. Seek emergency care for allergic reactions (rash, itching, swelling, dyspnea). Inform your physician of all current medications, including over-the-counter drugs. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential increased drowsiness. While driving impairment is uncommon, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, nutritious food, and hydration promote faster recovery. Your doctor may order tests to monitor the medication's effects.
Primary Ingredients of Cefs-S 500mg/250mg Injection
No information provided. A rephrased version cannot be created.
Uses of Cefs-S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Cefs-S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cefs-S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefs-S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Cefs-S 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Cefs-S 500mg/250mg Injection, offer a dual-action approach to bacterial infection. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, complements this action by counteracting bacterial resistance mechanisms, thus boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Cefs-S 500mg/250mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Cefdinir 500mg/250mg injection is typically deemed safe for use during gestation. Preclinical trials using animal models revealed minimal or no negative consequences for fetal development; nonetheless, clinical data from human subjects are scarce.
Breast feedingCAUTION
Administering Cefs-S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Cefs-S 500mg/250mg Injection can lead to reduced alertness, visual disturbances, drowsiness, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Cefs-S 500mg/250mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Administering Cefs-S 500mg/250mg Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Altering the Cefs-S 500mg/250mg Injection dosage is generally unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cefs-S 500mg/250mg Injection :
Should you forget a dose of Cefs-S 500mg/250mg Injection, seek your physician's advice.
Facts to Know About Cefs-S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently